FGF4 and breast cancer: We selected the EF43.fgf4 syngeneic mouse mammary tumor as a model of a highly aggressive TNBC where features of the microenvironment such as angiogenesis and inflammatory infiltrating cells (TAMs) are biologically important for tumor progression.